Morocco Stockpiles Chloroquine Drug for Potential COVID-19 Treatment
In the eyes of the Moroccan authorities, chloroquine could be a cure for the coronavirus. The Ministry of Health has purchased stocks of nivaquine, an antimalarial drug based on chloroquine, produced by the French group, Sanofi, in its Casablanca factories.
According to RFI, Sanofi Maroc has confirmed this purchase operation, which is accompanied by an additional order. But these stocks of nivaquine will be exported to sub-Saharan Africa where the coronavirus pandemic tends to rage.
On Wednesday, the Head of Government, Saâdeddine El Otmani, wrote on his Twitter account that Plaquenil can be used to treat all COVID-19 patients. Since tests have been carried out in France, there is a rush on Plaquenil stocks in pharmacies, a media outlet reports.
Related Articles
-
Moroccan Official Reassigned After Assault; Attacker Sentenced to Prison
19 April 2025
-
Ryanair’s Abrupt Cancellation of Malaga-Nador Route Sparks Outrage Among Moroccan Expats
19 April 2025
-
Moroccan Court Orders Repayment as Swiss Entrepreneur’s Textile Firm Faces Bankruptcy
19 April 2025
-
Moroccan Officials Under Investigation for Undeclared Foreign Assets and Bitcoin Trafficking
19 April 2025
-
Moroccan Real Estate Developers Accused of Tax Evasion Scheme in Jorf El Melha
19 April 2025